Volume 97, Issue 1, Pages (April 1999)

Slides:



Advertisements
Similar presentations
Ann Intern Med. 1993;119(10): doi: / Figure Legend:
Advertisements

Alain Verreault, Paul D Kaufman, Ryuji Kobayashi, Bruce Stillman  Cell 
Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors  Xu Luo, Imawati.
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Structural Changes in TAF4b-TFIID Correlate with Promoter Selectivity
Volume 41, Issue 5, Pages (March 2011)
Volume 6, Issue 3, Pages (September 2000)
Kristina M. Johnson, Michael Carey  Current Biology 
Volume 94, Issue 1, Pages (July 1998)
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Volume 3, Issue 1, Pages (January 1999)
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Ho-Geun Yoon, Doug W. Chan, Albert B. Reynolds, Jun Qin, Jiemin Wong 
Volume 45, Issue 1, Pages (January 2012)
Volume 107, Issue 4, Pages (November 2001)
ATP-Dependent Positive Supercoiling of DNA by 13S Condensin: A Biochemical Implication for Chromosome Condensation  Keiji Kimura, Tatsuya Hirano  Cell 
Stabilization of Chromatin Structure by PRC1, a Polycomb Complex
Genetically Encoded but Nonpolypeptide Prolyl-tRNA Functions in the A Site for SecM- Mediated Ribosomal Stall  Hiroki Muto, Hitoshi Nakatogawa, Koreaki.
Volume 89, Issue 3, Pages (May 1997)
Alain Verreault, Paul D Kaufman, Ryuji Kobayashi, Bruce Stillman  Cell 
The Nuclear Hat1p/Hat2p Complex
John F Ross, Xuan Liu, Brian David Dynlacht  Molecular Cell 
Volume 103, Issue 3, Pages (October 2000)
Volume 5, Issue 6, Pages (June 2000)
Transcriptional Fidelity and Proofreading by RNA Polymerase II
Volume 123, Issue 2, Pages (October 2005)
Volume 3, Issue 3, Pages (March 1999)
Volume 92, Issue 4, Pages (February 1998)
Nature of the Nucleosomal Barrier to RNA Polymerase II
A TRF1:BRF Complex Directs Drosophila RNA Polymerase III Transcription
Volume 38, Issue 3, Pages (May 2010)
Theodora Agalioti, Guoying Chen, Dimitris Thanos  Cell 
Ana Losada, Tatsuya Hirano  Current Biology 
DNA Topoisomerase I and PC4 Can Interact with Human TFIIIC to Promote Both Accurate Termination and Transcription Reinitiation by RNA Polymerase III 
Volume 125, Issue 2, Pages (April 2006)
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
Volume 86, Issue 1, Pages (July 1996)
Volume 11, Issue 24, Pages (December 2001)
Pcf11 Is a Termination Factor in Drosophila that Dismantles the Elongation Complex by Bridging the CTD of RNA Polymerase II to the Nascent Transcript 
Dimitra J. Mitsiou, Hendrik G. Stunnenberg  Molecular Cell 
Gaku Mizuguchi, Toshio Tsukiyama, Jan Wisniewski, Carl Wu 
TopBP1 Activates the ATR-ATRIP Complex
Polypyrimidine Tract Binding Protein Blocks the 5′ Splice Site-Dependent Assembly of U2AF and the Prespliceosomal E Complex  Shalini Sharma, Arnold M.
Volume 12, Issue 2, Pages (August 2003)
Volume 95, Issue 2, Pages (October 1998)
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
Pathway Leading to Correctly Folded β-Tubulin
Volume 123, Issue 4, Pages (November 2005)
Volume 2, Issue 2, Pages (August 1998)
Volume 21, Issue 2, Pages (January 2006)
Human Pre-mRNA Cleavage Factor Im Is Related to Spliceosomal SR Proteins and Can Be Reconstituted In Vitro from Recombinant Subunits  Ursula Rüegsegger,
Volume 87, Issue 5, Pages (November 1996)
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Regulation of Yeast mRNA 3′ End Processing by Phosphorylation
Volume 45, Issue 1, Pages (January 2012)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
Reconstitution of the Transcription Factor TFIIH
Volume 119, Issue 2, Pages (October 2004)
Volume 9, Issue 1, Pages (January 2002)
Volume 7, Issue 6, Pages (June 2001)
A Minimal RNA Polymerase III Transcription System from Human Cells Reveals Positive and Negative Regulatory Roles for CK2  Ping Hu, Si Wu, Nouria Hernandez 
Functional Coupling of Capping and Transcription of mRNA
Volume 104, Issue 1, Pages (January 2001)
Volume 3, Issue 1, Pages (January 1999)
Volume 123, Issue 2, Pages (October 2005)
A SWI/SNF–Related Chromatin Remodeling Complex, E-RC1, Is Required for Tissue- Specific Transcriptional Regulation by EKLF In Vitro  Jennifer A Armstrong,
Volume 84, Issue 2, Pages (January 1996)
Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Presentation transcript:

Volume 97, Issue 1, Pages 41-51 (April 1999) NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation  Yuki Yamaguchi, Toshiyuki Takagi, Tadashi Wada, Keiichi Yano, Akiko Furuya, Seiji Sugimoto, Jun Hasegawa, Hiroshi Handa  Cell  Volume 97, Issue 1, Pages 41-51 (April 1999) DOI: 10.1016/S0092-8674(00)80713-8

Figure 1 Identification of the Activity Required for DRB-Sensitive Transcription (A) Diagram showing the reconstitution of DRB-sensitive transcription. HeLa nuclear extract was first applied to a phosphocellulose (P11) column, yielding three fractions, P.1, P.3, and P1.0. P1.0 was sufficient for transcription and was further fractionated on DEAE Sepharose and phenyl Superose columns. (B) Transcription in the crude P1.0 system. Using the P1.0 fraction, the effect of crude (P.1/P.3 conc) and purified (rDSIF) preparations of DSIF was compared. Both were found to equally induce DRB sensitivity. (C) Transcription in the reconstituted system. The effect of crude and purified DSIF preparations was compared using the reconstituted system containing the phenyl flowthrough (φFT), rTFIIB, rTFIIE, and rTFIIF. rDSIF alone did not induce DRB sensitivity in this system (lanes 11 and 12). Further addition of P.3 (P.3 dil) restored DRB sensitivity (lanes 13–18), indicating the presence of another DRB sensitivity–inducing activity in P.3. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 2 Purification of Negative Elongation Factor (A) Scheme for NELF purification. NELF was purified from P.3 using the reconstituted system plus rDSIF as an assay. P-TEFb derived from P1.0 was additionally included in the reactions at later steps of purification. (B) NELF activity on the mono S column. Mono S fractions (2 μl) were assayed for NELF activity in the presence or absence of P-TEFb. NELF activity was found in fractions 20–26 only in the presence of P-TEFb. The mono S fractions (2 μl) were also resolved by 7.5% SDS-PAGE, and the gel was stained with silver. Five different bands of 66, 61, 59, 58, and 46 kDa (indicated by arrows) were associated with the activity. IN, input; FT, flowthrough. (C) Transcription repression by NELF. The effect of purified NELF (mono S) was examined in the presence or absence of P-TEFb as in (B). Without P-TEFb, NELF potently repressed transcription, while the addition of P-TEFb partly relieved the repression in a DRB-sensitive manner. (D) Gel filtration of purified NELF. Fifty microliters purified of NELF (mono S) was applied to a Superdex 200 gel filtration column. An aliquot (10 μl) of each eluate fraction was assayed for NELF activity in the presence of P-TEFb as in (B), or stained with silver. The five polypeptides were coeluted with NELF activity at an apparent molecular mass of ∼300 kDa and termed NELF-A to -E in accordance with their decreasing molecular weights. The positions of the native molecular weight markers are indicated at the bottom. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 3 NELF Acts Cooperatively with DSIF to Repress Pol II Transcription (A) Cooperative action of DSIF and NELF on promoter-specific transcription. The indicated amounts of r-DSIF and NELF (mono S) were added to the reconstituted system lacking P-TEFb. Two transcripts are generated from the adenovirus E4 and major late (ML) promoters. Transcripts from the ML promoter are less sensitive to repression. The vertical bar indicates the accumulation of short transcripts caused by DSIF and NELF. (B) Proteins used in (C) were resolved by 7.5% (left) or 12.5% (right) SDS-PAGE and stained with silver. The amounts used are purified pol II, 0.5 μl; rDSIF, 2 μl; purified NELF, 2 μl. Pol II was mostly in the IIa form. (C) Cooperative action of DSIF and NELF on the oligo dC-tailed template. Purified pol II and the template were preincubated together with the indicated protein factors. NTPs were added, and elongation was allowed to proceed for the indicated times. (D) Pol IIo, pol IIa, and pol IIb were prepared as described in Experimental Procedures, and the amounts used in (E) were analyzed by 7.5% SDS-PAGE and silver staining. (E) The different forms of pol II were assayed for elongation in the presence or absence of DSIF and NELF (2 μl each). Pol IIa and pol IIb, but not pol IIo, were susceptible to DSIF and NELF. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 5 Immunodepletion of NELF from HeLa Nuclear Extract (A) Specificity of anti-RD antibody. Anti-RD antibody raised against the full-length RD protein was tested for immunoblotting. The antibody detected a single band of ∼46 kDa in the nuclear extract and purified NELF (mono S). (B) Immunoblot analysis of the nuclear extracts depleted of RD. HeLa nuclear extract (200 μl) was repeatedly passed over protein G-Sepharose (20 μl) to which either anti-RD or preimmune serum was adsorbed. The supernatants (2 μl) were analyzed for the presence of RD, DSIF p160, the CDK9 subunit of P-TEFb, and the largest subunit of pol II by immunoblotting. Two or four passages over the anti-RD beads reduced or eliminated the endogenous RD protein (ΔRDx2 and ΔRDx4), while the level of other components remained constant. Depletion with the control beads had no effect. (C) Transcription activity of the RD-depleted extract. The extracts (2 μl) were assayed using pTF3-C2AT and pML-dC2AT. Depletion of RD did not significantly affect transcription in the absence of DRB. In its presence, however, RD depletion alleviated transcription repression, resulting in a reduction in DRB sensitivity. (D) Readdition of NELF. D.225 signifies the 0.225 M KCl fraction from DEAE Sepharose, which was free from DSIF. D.225 (6 μl) and purified NELF (mono S; 2 μl) were added back to the RD-depleted extract (ΔRDx4). In both cases, the addition of NELF repressed transcription in the presence of DRB and restored DRB sensitivity. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 7 Kinetic Analysis of DSIF/NELF Function (A) Primer extension analysis. Transcripts were synthesized from pTF3-6C2AT using either the normal HeLa nuclear extract in the presence or absence of 50 μM DRB (left) or the extract depleted of NELF and P-TEFb with or without 1 μl NELF (right). They were analyzed using a set of oligonucleotide primers labeled to the same specific activity. M lanes show the pBR322 MspI digest. The extension products, marked with the dots, were quantified using a FLA-2000 image analyzer (Fuji), and the amounts (in arbitrary units) were plotted against the length from the transcription start site (top). Indicated in the inset are the positions of transcripts to which the primers hybridized. Longer transcripts may be underestimated due to the reduced efficiency of reverse transcription. (B) Effect of DSIF and NELF on isolated elongation complexes. Purified pol II and the oligo dC-tailed template carrying a 380 nt C-free cassette at its dC end were incubated in the presence of NTP lacking CTP, and the paused elongation complexes were allowed to form on the template. DSIF and NELF were added where indicated, and elongation was allowed to resume for the indicated times by adding CTP. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 4 Identification of NELF-E as RD The active fractions from mono S were subjected to SDS-PAGE, and the band of 46 kDa corresponding to NELF-E was subjected to microsequence analysis. Two peptide sequences (underlined) were obtained and found to match parts of the human RD protein (Cheng et al. 1993; GenBank accession No. L03411). The RD motif and the putative RRM are indicated by arrows. Asterisks denote Leu residues of the putative leucine zipper structure. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 6 NELF Interacts with DSIF and Pol II Nuclear extracts were prepared from HeLa/Flag-RD and control HeLa cells by the method of Dignam et al. 1983. The extracts (200 μl) were immunoprecipitated with anti-Flag M2 monoclonal antibody (Sigma) under transcription conditions, washed, and eluted with Flag peptide (Sigma). Each fraction was analyzed by immunoblotting with the indicated antibodies. Input and FT lanes represent 4% of the total amount. Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)

Figure 8 Interplay between DSIF, NELF, and P-TEFb Cell 1999 97, 41-51DOI: (10.1016/S0092-8674(00)80713-8)